Early success in the inaugural transplant of a pig kidney into a human recipient has sparked optimism among researchers for broader clinical trials involving pig organs. These trials could pave the way for xenotransplantation, the utilization of animal organs in human patients, to become a viable medical option. The recipient of the pig kidney, 62-year-old Richard Slayman, who suffered from end-stage renal failure, is reportedly recovering well following his surgery on March 16th, as confirmed by his transplant surgeon. The kidney was sourced from a miniature pig carrying an impressive 69 genomic edits, aimed at minimizing organ rejection and mitigating the risk of viral transmission to the recipient. Luhan Yang, CEO of Qihan Biotech in Hangzhou, China, and a founder of eGenesis in Cambridge, Massachusetts, the biotech firm responsible for producing the genetically modified pigs, asserts that this case demonstrates the short-term safety and functionality of these organs as viable kidney replacements. Watch to know more
External Affairs Minister Sushma Swaraj today underwent a kidney transplant at AIIMS, with the organ being harvested from a living unrelated donor.
"The Zydus group will market this therapy through Zydus Trans-immune, a division that offers a range of therapies related to transplant medicine," group firm Cadila Healthcare said in a filing to BSE.